Showing 1120 – 1130 of 1157 results
-
Two Retinal Disease Therapies Companies Initiations
William Blair initiated research coverage of Kalaris Therapeutics, Inc. (KLRS $7.08) and Ocular Therapeutix, Inc. (OCUL $6.36), both biotechnology companies developing therapies for the treatment of retinal vascular diseases.
-
Immunic, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Immunic, Inc. (IMUX $1.13), a clinical-stage biotech developing novel therapies for chronic inflammatory and autoimmune disorders.
-
Initiation of Three Companies in the Nuclear Power Industry
William Blair initiated research coverage of BWX Technologies, Inc. (BWXT $119.49), Centrus Energy Corp. (LEU $113.29), and Oklo Inc. (OKLO $48.87).
-
Three Leading Waste and Recycling Companies Initiation
William Blair initiated research coverage of Casella Waste Systems, Inc. (CWST $98.52), Republic Services, Inc. (RSG $201.28), and Waste Management, Inc. (WM $207.93), leading providers of solid waste and recycling solutions.
-
Aardvark Therapeutics Inc Initiation
William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
-
Why One Mans Trash is an Investors Treasure
In this episode of William Blair Thinking Presents, global services sector analyst Trevor Romeo dives into his team’s latest white paper on the North American waste and recycling industry, exploring key structural trends and the growing imbalance between waste generation and landfill capacity.
-
Monthly Macro with Richard de Chazal December 2024
William Blair macro analyst Richard de Chazal looks back at the economic highlights of 2024 and shares his insights and predictions for the U.S. economy in 2025, emphasizing resilience, consumer strength, and potential risks ahead.
-
Monthly Macro with Richard de Chazal September 2023
Housing, retail sales, and the Sahm Rule. Hear what macro analyst Richard de Chazal outlines in his latest Monthly Macro podcast, and what’s in store for the markets as we near a critical FOMC meeting next month.
-
William Blair Analysts Share Insights on Advances in COVID Vaccines and Testing
Tim Lugo and Brian Weinstein provide an update on vaccines, testing, and the companies leading the efforts.
-
Private Capital Advisory Newsletter
In this quarterly update, William Blair’s Private Capital Advisory team outlines the encouraging signs in the secondaries landscape, hopes for Q4, creative solutions, and what to expect from GP-Led secondary transactions.